日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments

相关靶向治疗对KRAS突变非小细胞肺癌细胞系PD-L1表达的影响研究

Anna Minchom, Parames Thavasu, Zai Ahmad, Adam Stewart, Alexandros Georgiou, Mary E R O'Brien, Sanjay Popat, Jaishree Bhosle, Timothy A Yap, Johann de Bono, Udai Banerji

Evaluation of the combination of the dual m-TORC1/2 inhibitor vistusertib (AZD2014) and paclitaxel in ovarian cancer models

双重 m-TORC1/2 抑制剂 vistusertib (AZD2014) 与紫杉醇联合用于卵巢癌模型的评估

Anne-Christine Wong Te Fong, Parames Thavasu, Sladjana Gagrica, Karen E Swales, Martin O Leach, Sabina C Cosulich, Yuen-Li Chung, Udai Banerji

The association of PI3 kinase signaling and chemoresistance in advanced ovarian cancer

PI3 激酶信号与晚期卵巢癌化疗耐药的关系

Craig P Carden, Adam Stewart, Parames Thavasu, Emma Kipps, Lorna Pope, Mateus Crespo, Susana Miranda, Gerhardt Attard, Michelle D Garrett, Paul A Clarke, Paul Workman, Johann S de Bono, Martin Gore, Stan B Kaye, Udai Banerji